Transcript of earnings conference call with Analyst/ Investors held on 13th May, 2025
Awaiting price reaction for this filing.
KIMS Hospitals reported FY25 total revenue of INR 3,067 crore (+22% YoY), EBITDA of INR 815 crore (+24.7% YoY) with margins improving to 26.6% from 26%, and PAT of INR 415 crore vs INR 336 crore in FY24. Q4 FY25 revenue grew 25.7% YoY to INR 801 crore, while EBITDA was INR 203 crore at 25.3% margins. ARPOB grew 22.7% YoY and IP volumes rose 11.6%. New units (Nashik, Sangli, Kannur, Kollam, Guntur, Thane) contributed INR 76 crore revenue but INR 17.89 crore EBITDA loss in Q4. Management opened a second Vizag unit in April, soft-launched Thane, and plans two Bangalore hospitals by July-August 2025. Net debt stood at INR 1,805 crore as of March 2025, with capex of INR 600-700 crore planned over the next two years.
Positive on revenue growth trajectory, but short-term margin pressure expected in FY26 due to fixed costs from 3 new hospital commissions (Thane and 2 Bangalore). Telangana cluster continues to drive profitability with 20% growth runway, while new units are expected to turn EBITDA neutral within 12 months of commissioning, supporting medium-term earnings growth.